Notice of republication
This article was republished on October 5, 2020, to include a Publisher’s Note. The Publisher’s Note was added to clarify that the article is a pre-registered research article and to provide information about the assessment process administered by Children’s Tumor Foundation (CTF) and PLOS ONE. Please download the article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.
Supporting information
S1 File. Originally published, uncorrected article.
https://doi.org/10.1371/journal.pone.0249380.s001
(PDF)
Reference
- 1. Vasiljevski ER, Houweling PJ, Rupasinghe T, Kaur T, Summers MA, Roessner U, et al. (2020) Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1). PLoS ONE 15(8): e0237097. https://doi.org/10.1371/journal.pone.0237097 pmid:32810864
Citation: The PLOS ONE Staff (2021) Correction: Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1). PLoS ONE 16(3): e0249380. https://doi.org/10.1371/journal.pone.0249380
Published: March 24, 2021
Copyright: © 2021 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.